Hyperfine (HYPR) Other Non-Current Liabilities (2023 - 2026)

Hyperfine's (HYPR) quarterly Other Non-Current Liabilities came in at $17000.0 in Q1 2026, down 74.24% on a QoQ basis from $66000.0 in Q4 2025.

Hyperfine (HYPR) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends

Hyperfine (HYPR) has 4 years of Other Non-Current Liabilities data on file, last reported at $17000.0 in Q1 2026.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17000.0 (changed N/A YoY) and the FY2025 annual result came in at $66000.0, down 15.38% from the prior year.
Other Non-Current Liabilities slipped to $17000.0 in Q1 2026, from $66000.0 in the prior quarter.
In the past five years, Other Non-Current Liabilities ranged from a high of $78000.0 in Q4 2024 to a low of $12000.0 in Q2 2025.
A 4-year average of $47400.0 and a median of $64000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
Annual changes were most pronounced in 2024 — Other Non-Current Liabilities rose 21.88% — and 2025, when it declined 15.38%.
Tracing HYPR's Other Non-Current Liabilities over 4 years: stood at $64000.0 in 2023, then climbed by 21.88% to $78000.0 in 2024, then decreased by 15.38% to $66000.0 in 2025, then plunged by 74.24% to $17000.0 in 2026.
The last three Other Non-Current Liabilities figures came in at $17000.0 (Q1 2026), $66000.0 (Q4 2025), and $12000.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Hyperfine	89.83 Mn	45.06 Mn	1.98 Mn

Download Data